Thomas E. Eling

17.7k total citations · 2 hit papers
294 papers, 15.0k citations indexed

About

Thomas E. Eling is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Thomas E. Eling has authored 294 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Pharmacology, 103 papers in Molecular Biology and 79 papers in Biochemistry. Recurrent topics in Thomas E. Eling's work include Inflammatory mediators and NSAID effects (129 papers), Eicosanoids and Hypertension Pharmacology (69 papers) and GDF15 and Related Biomarkers (52 papers). Thomas E. Eling is often cited by papers focused on Inflammatory mediators and NSAID effects (129 papers), Eicosanoids and Hypertension Pharmacology (69 papers) and GDF15 and Related Biomarkers (52 papers). Thomas E. Eling collaborates with scholars based in United States, Japan and South Korea. Thomas E. Eling's co-authors include Seung Joon Baek, Ronald P. Mason, P. David Josephy, Leigh C. Wilson, Wayne C. Glasgow, John F. Curtis, Linda C. Hsi, Kandiah Sivarajah, Jennifer B. Nixon and Hideki Kamitani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thomas E. Eling

290 papers receiving 14.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. Free radical and charge-transfer complex intermediates.

1982 845 citations P. David Josephy, Thomas E. Eling et al. profile →
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

2007 641 citations Thomas E. Eling et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas E. Eling	5.7k	3.5k	2.9k	2.6k	2.3k	294	15.0k
Alan M. Fogelman	8.5k 1.5×	2.1k 0.6×	2.2k 0.8×	1.5k 0.6×	7.2k 3.2×	266	31.5k
Peter C. Isakson	3.5k 0.6×	9.2k 2.6×	1.9k 0.7×	704 0.3×	2.2k 1.0×	134	16.8k
Giuseppe Cirino	5.5k 1.0×	2.4k 0.7×	4.7k 1.6×	589 0.2×	2.4k 1.0×	288	17.9k
Neil Kaplowitz	8.4k 1.5×	1.2k 0.3×	1.9k 0.6×	1.4k 0.5×	1.3k 0.6×	314	30.6k
David L. DeWitt	4.8k 0.8×	9.1k 2.6×	1.6k 0.6×	420 0.2×	1.7k 0.7×	109	17.4k
John Baynes	8.2k 1.4×	1.1k 0.3×	6.9k 2.4×	1.1k 0.4×	1.2k 0.5×	211	29.2k
Ian A. Blair	10.0k 1.7×	1.7k 0.5×	2.1k 0.7×	338 0.1×	2.3k 1.0×	421	21.1k
Jay W. Heinecke	8.4k 1.5×	1.2k 0.3×	6.4k 2.2×	977 0.4×	8.9k 3.9×	266	29.3k
Karen Seibert	3.9k 0.7×	11.2k 3.2×	2.2k 0.8×	549 0.2×	1.1k 0.5×	99	18.8k
Timothy D. Warner	3.9k 0.7×	3.5k 1.0×	6.3k 2.2×	336 0.1×	1.2k 0.5×	252	15.5k

Countries citing papers authored by Thomas E. Eling

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Eling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Eling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Eling more than expected).

Fields of papers citing papers by Thomas E. Eling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Eling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Eling. The network helps show where Thomas E. Eling may publish in the future.

Co-authorship network of co-authors of Thomas E. Eling

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Eling. A scholar is included among the top collaborators of Thomas E. Eling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Eling. Thomas E. Eling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ryu, Junsun, et al.. (2025). NAG-1/GDF15 as a tumor suppressor in colorectal cancer: inhibition of β-catenin and NF-κB pathways via interaction with EpCAM. Cell Death and Disease. 16(1). 355–355.

Li, Ruifang, Sara A. Grimm, Kaliopi Chrysovergis, et al.. (2014). Obesity, Rather Than Diet, Drives Epigenomic Alterations in Colonic Epithelium Resembling Cancer Progression. Cell Metabolism. 19(4). 702–711. 55 indexed citations

Whitlock, Nichelle C., Jae Hoon Bahn, Seong‐Ho Lee, Thomas E. Eling, & Seung Joon Baek. (2011). Resveratrol-Induced Apoptosis Is Mediated by Early Growth Response-1, Krüppel-Like Factor 4, and Activating Transcription Factor 3. Cancer Prevention Research. 4(1). 116–127. 41 indexed citations

Iguchi, Genzo, Kali Chrysovergis, Seong‐Ho Lee, et al.. (2009). A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2. Cancer Letters. 282(2). 152–158. 27 indexed citations

Iguchi, Genzo, et al.. (2008). Regulation of EP4 expression via the Sp-1 transcription factor: Inhibition of expression by anti-cancer agents. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(6). 1211–1219. 27 indexed citations

Bottone, Frank G., Seung Joon Baek, Jennifer B. Nixon, & Thomas E. Eling. (2002). Diallyl Disulfide (DADS) Induces the Antitumorigenic NSAID-Activated Gene (NAG-1) by a p53-Dependent Mechanism in Human Colorectal HCT 116 Cells. Journal of Nutrition. 132(4). 773–778. 102 indexed citations

Glasgow, Wayne C., et al.. (1996). Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.. Molecular Pharmacology. 49(6). 1042–1048. 10 indexed citations

Duniec, Z, Paul Nettesheim, & Thomas E. Eling. (1991). Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C.. Molecular Pharmacology. 39(2). 164–170. 17 indexed citations

Thompson, David R. & Thomas E. Eling. (1989). Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.. Molecular Pharmacology. 36(5). 809–817. 52 indexed citations

10.

Schreiber, J., Ronald P. Mason, & Thomas E. Eling. (1986). Detection of glutathione free radical catalyzed by prostaglandin hydroperoxidase present in intact epidermal cells. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 2 indexed citations

11.

Boyd, Jeff & Thomas E. Eling. (1985). Metabolism of aromatic amines by prostaglandin H synthase.. Environmental Health Perspectives. 64. 45–51. 26 indexed citations

12.

Eling, Thomas E. & A.I. Ally. (1984). Pulmonary biosynthesis and metabolism of prostaglandins and related substances.. Environmental Health Perspectives. 55. 159–168. 18 indexed citations

13.

Josephy, P. David, Thomas E. Eling, & Ronald P. Mason. (1983). An electron spin resonance study of the activation of benzidine by peroxidases.. Molecular Pharmacology. 23(3). 766–770. 41 indexed citations

14.

Sivarajah, Kandiah, Jerome M. Lasker, Thomas E. Eling, & M. B. Abou-Donia. (1982). Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.. Molecular Pharmacology. 21(1). 133–141. 23 indexed citations

15.

Wilson, Alan, R.D. Pickett, Thomas E. Eling, & M. Anderson. (1979). STUDIES ON THE PERSISTENCE OF BASIC AMINES IN THE RABBIT LUNG. Drug Metabolism and Disposition. 7(6). 420–424. 26 indexed citations

16.

Anderson, M. & Thomas E. Eling. (1976). Studies on the uptake, metabolism, and release of endogenous and exogenous chemicals by use of the isolated perfused lung. Environmental Health Perspectives. 16. 77–81. 9 indexed citations

17.

Pickett, R.D., M. Anderson, T.C. Orton, & Thomas E. Eling. (1975). The pharmacodynamics of 5-hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.. Journal of Pharmacology and Experimental Therapeutics. 194(3). 545–553. 32 indexed citations

18.

Oswald, E.O., et al.. (1974). Characterization of prostaglandins by combined gas-liquid chromatography and chemical ionization mass spectrometry. Journal of Chromatography A. 93(1). 47–62. 22 indexed citations

19.

Anderson, M., T.C. Orton, R.D. Pickett, & Thomas E. Eling. (1974). ACCUMULATION OF AMINES IN THE ISOLATED PERFUSED RABBIT LUNG. Journal of Pharmacology and Experimental Therapeutics. 189(2). 456–466. 80 indexed citations

20.

Orton, T.C., M. Anderson, R.D. Pickett, Thomas E. Eling, & James R. Fouts. (1973). XENOBIOTIC ACCUMULATION AND METABOLISM BY ISOLATED PERFUSED RABBIT LUNGS. Journal of Pharmacology and Experimental Therapeutics. 186(3). 482–497. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact